Dec-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has demonstrated consistent performance in the Arizona market, particularly in the Tincture & Sublingual category where it has maintained a steady rank of 2nd place from September through December 2024. This stability is indicative of strong consumer loyalty and effective marketing strategies in this category. Meanwhile, the Topical category saw a notable improvement, with Chronic Health advancing from 3rd place in the previous months to 2nd place by December. This upward movement suggests a growing consumer preference for their topical products, possibly driven by enhanced product offerings or increased brand visibility in the state.
While Chronic Health has shown impressive results in Arizona, the absence of rankings in other states or provinces indicates potential areas for expansion or increased competition that may need addressing. The lack of top 30 rankings outside of Arizona could be viewed as a challenge for the brand, highlighting the need for strategic initiatives to boost visibility and market share in other regions. The brand's ability to maintain and improve its position in Arizona serves as a promising foundation for potential growth in new markets, provided they can replicate their successful strategies from Arizona elsewhere.
Competitive Landscape
In the competitive landscape of the Arizona topical cannabis market, Chronic Health has demonstrated a notable upward trajectory in its rankings over the last quarter of 2024. Chronic Health maintained a steady third position in September, October, and November, before climbing to the second spot in December. This rise in rank is indicative of a positive trend in sales performance, as Chronic Health's sales figures have shown consistent growth, culminating in a significant increase by December. Meanwhile, Drip Oils + Extracts emerged as a formidable competitor, jumping from fourth place in September to secure the top rank in both October and December, with sales surpassing those of Chronic Health. iLava, which started the period as the market leader, experienced fluctuations, ultimately dropping to third place by December. Tru Infusion maintained a stable position at fourth, indicating a less volatile market presence. These dynamics suggest that while Chronic Health is gaining ground, it faces intense competition from brands like Drip Oils + Extracts, which are also experiencing strong sales momentum.
Notable Products
In December 2024, the top-performing product for Chronic Health was the CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) in the Tincture & Sublingual category, maintaining its number one rank from previous months with sales reaching 692 units. The CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) also performed well, holding the second position, a recovery from its fourth position in November, with a notable increase in sales. The Indica THC Glycerin Tincture (100mg THC, 1oz) consistently ranked third, showing stable demand. The CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC) ranked fourth, dropping from its second position in November, indicating a shift in consumer preference. A new entry in the rankings, the CBD/THC 1:1 Pain Relief Roll-On (50mg CBD, 50mg THC), debuted at the fifth position, suggesting growing interest in topical products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.